Eye Dose Reduction with Various X-ray Protection Shields during Endovascular Procedures

Autor:	L. Jangland, S. Bruce, Anders Wanhainen, K. Lindskog, Kevin Mani
Rok vydání:	2016
Předmět:	medicine.medical_specialty business.industry Cancer medicine.disease Intermittent claudication Coronary artery disease Total mortality Internal medicine medicine Population study Surgery Dose reduction medicine.symptom Cardiology and Cardiovascular Medicine business Complication
Zdroj:	European Journal of Vascular and Endovascular Surgery. 52:417
ISSN:	1078-5884
Popis:	s 417 Introduction: Patients with intermittent claudication carry a high risk for cardiovascular complications. The TransAtlantic Inter-Society Consensus (TASC) Group estimated a five year total mortality of up to 30% for these patients, the majority dying due to cardiovascular causes. We investigated whether this evaluation is still applicable in nowadays patients. Methods: The CAVASIC Study included 255 male PAD patients with intermittent claudication who were prospectively followed for a median of 7 years. During follow-up overall mortality, vascular morbidity and mortality as well as local PAD outcomes were assessed. Results: During entire follow-up, overall mortality reached 16.1% (n 1⁄4 41). Most patients died from cancer (n 1⁄4 20). Half of patients (n 1⁄4 22; 8.6%) died within the first five years. Incident cardiovascular events were observed among 70 patients (27.5%), 54 (21.2%) experienced a complication during the first five years. Vascular mortality was as low as 5.1% (n 1⁄4 13) for the entire and 3.1% for the first five years of follow-up. Prevalent coronary artery disease did not increase the risk to die from all or vascular causes. PAD symptoms stayed stable or improved in the majority of patients (67%) during follow-up. Patients with PAD treatment at baseline carried a higher risk for reintervention after three years of follow-up. Conclusion: Compared with proposed frequency estimates from TASC the proportion of cardiovascular events did not markedly decrease over the last 2 decades. Vascular mortality, however, was surprisingly low among our study population. The data at hand might indicate that nowadays patients more frequently survive cardiovascular events. A relevant number died from cancer. Disclosure of Interest: None Declared.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8ed033577f3062abd25c27354fb3a98d https://doi.org/10.1016/j.ejvs.2016.07.080 Zobrazit plný text záznamu Full Text from ScienceDirect